Bhat; Sreenivas S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bhat; Sreenivas S..The latest application filed is for "pharmaceutical compositions comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-y- l)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same".

Company Profile

3.10.7

Bhat; Sreenivas S. - Kendall Park NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tablet compositions Grant 11,389,454 - Bhat , et al. July 19, 2	2022-07-19
Pharmaceutical Compositions Comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-y- L)methyl)benzyl)amino)isoindoline-1,3-dione And Methods Of Using The Same App 20210113575 - Bhat; Sreenivas S. ; et al.	2021-04-22
Formulations Of (+)-2-[1-(3-ethoxy-4- Methoxy-phenyl)-2-methanesulfonyl- Ethyl]-4-acetylaminoisoindoline-1,3- Dione App 20210093573 - Bhat; Sreenivas S. ; et al.	2021-04-01
Pharmaceutical tablet Grant D858,741 - Parikh , et al. Sep	2019-09-03
Pharmaceutical tablet Grant D835,258 - Parikh , et al. De	2018-12-04
Pharmaceutical tablet Grant D835,257 - Parikh , et al. De	2018-12-04
Pharmaceutical tablet Grant D813,372 - Parikh , et al. March 20, 2	2018-03-20
Tablet Compositions App 20180064715 - Bhat; Sreenivas S. ; et al.	2018-03-08
Pharmaceutical tablet Grant D787,042 - Parikh , et al. May 16, 2	2017-05-16
Pharmaceutical tablet Grant D787,043 - Parikh , et al. May 16, 2	2017-05-16
Pharmaceutical formulations of a substituted diaminopurine Grant 9,198,866 - Bhat , et al. December 1, 2	2015-12-01
Formulations Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione App 20150196562 - BHAT; Sreenivas S.	2015-07-16
Pharmaceutical Formulations Of A Substituted Diaminopurine App 20140093566 - Bhat; Sreenivas S. ; et al.	2014-04-03
Pharmaceutical formulations of a substituted diaminopurine Grant 8,603,527 - Bhat , et al. December 10, 2	2013-12-10
Formulations Of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylami- Noisoindoline-1,3-dione App 20130164376 - BHAT; Sreenivas S. ; et al.	2013-06-27
Pharmaceutical Formulations Of A Substituted Diaminopurine App 20120100213 - Bhat; Sreenivas S. ; et al.	2012-04-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.